Exhibit 31.1





Certification of the


Company’s Principal Executive Officer
and Chief Financial Officer


Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002


and Securities and Exchange Commission
Release 34-46427





I, Wayne D. Cockburn, certify
that:





1           I
have reviewed thisAmendment No.1 to the Registrant’sAnnual Report on Form 10-K(“Amendment No. 1”)for the fiscal year ended
December 31, 2008 of Impact Medical Solutions, Inc., a Delaware corporation (the
“Company”);





2.           Based
on my knowledge, thisAmendment No. 1does not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this Annual
Report;





3.           Based
on my knowledge, the financial statements, and other financial information
included in thisAmendment
No. 1, fairly present in
all material respects the financial condition, results of operations and cash
flows of the Company as of, and for, the periods present in this Annual
Report;





4.           The
Company’s other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for Company and
have:





(a)           Designed
such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material
information relating to the Company, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period
in which thisAmendment No.
1is being
prepared;





(b)           Designed
such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principals;





(c)           Evaluated
the effectiveness of the Company’s disclosure controls and procedures and
presented in thisAmendment
No. 1our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this Annual Report based on such evaluation;
and





(d)           Disclosed
in thisAmendment No. 1any change in the Company’s
internal control over financing reporting that occurred during the Company’s
most recent fiscal quarter (the small business issuer’s fourth fiscal quarter in
the case of an Annual Report) that has materially affected, or is reasonably
likely to materially affect, the Company’s internal control over financial
reporting; and





5.           The
Company’s other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the Company’s
auditors and the audit committee of the Company’s board of directors (or persons
performing the equivalent functions):





(a)           All
significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonable likely to
adversely affect the Company’s ability to record, process, summarize and report
financial information; and





(b)           Any
fraud, whether or not material, that involved management or other employees who
have a significant role in the Company’s internal control over financial
reporting.







Dated:
      May 7, 2009
                /s/  Wayne D.
      CockburnWayne
      D. CockburnPresident,
      Chief Executive Officer,Secretary,
      Treasurer and Interim ChiefFinancial
      Officer and a Member of the Board of Directors(Principal
      Executive Officer and Principal Financial and
                  Accounting
      Officer)